Date Name Title Filing Type Shares Traded Price Total Held
Nov 05, 2015
EVP Research and Development
EVP Research and Development Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 935 $567.63 77,442
Nov 05, 2015
EVP Research and Development
EVP Research and Development Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 13,312 $567.63 64,130
Apr 20, 2020
EVP Finance CFO
EVP Finance CFO Form 4 Open market or private sale of non-derivative or derivative security 114 $567.76 25,063
Apr 20, 2020
EVP Finance CFO
EVP Finance CFO Form 4 Open market or private sale of non-derivative or derivative security 126 $568.11 24,937
May 07, 2020
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 609 $568.37 656
Jul 01, 2021
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 13 $568.43 23,491
May 21, 2020
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 11,447 $568.43 326,090
Nov 02, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Open market or private sale of non-derivative or derivative security 1,600 $568.49 578,216
May 07, 2020
EVP & General Mgr Industrial O
EVP & General Mgr Industrial O Form 4 Open market or private sale of non-derivative or derivative security 3,040 $568.57 28,951
May 12, 2020
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 18,021 $568.58 569,240

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.